Evidence map›Paper›PMID 36292170›Full record

ArticleDiagnostics (Basel, Switzerland)2022

Incidence of Acute Kidney Injury in Polytrauma Patients and Predictive Performance of TIMP2 × IGFBP7 Biomarkers for Early Identification of Acute Kidney Injury.

Gianlorenzo Golino, Massimiliano Greco, Alessandro Rigobello, Vinicio Danzi, Massimo De Cal, Nicola Malchiorna, Monica Zannella, Paolo Navalesi, Rahul Costa-Pinto, Claudio Ronco and 1 more

Open access · goldAbstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Observational
  3. Review
  4. Review
  5. Matrix metalloproteinases in kidney homeostasis and diseases: an update.American journal of physiology. Renal physiology · 2024
    Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Gianlorenzo GolinoInternational Renal Research Institute of Vicenza, 36100 Vicenza, Italy.
Massimiliano GrecoDepartment of Anesthesiology and Intensive Care, IRCCS Humanitas Research Hospital, 20100 Milan, Italy.ORCID 0000-0003-1003-4637
Alessandro RigobelloDepartment of Anesthesiology and Intensive Care, San Bortolo Hospital, 36100 Vicenza, Italy.
Vinicio DanziDepartment of Anesthesiology and Intensive Care, San Bortolo Hospital, 36100 Vicenza, Italy.
Massimo De CalInternational Renal Research Institute of Vicenza, 36100 Vicenza, Italy.ORCID 0000-0002-6383-4868
Nicola MalchiornaInternational Renal Research Institute of Vicenza, 36100 Vicenza, Italy.
Monica ZannellaInternational Renal Research Institute of Vicenza, 36100 Vicenza, Italy.
Paolo NavalesiDepartment of Medicine-DIMED, Section of Anesthesiology and Intensive Care Medicine, University of Padova, 35100 Padova, Italy.ORCID 0000-0002-3733-3453
Rahul Costa-PintoDepartment of Intensive Care, Austin Hospital, 145 Studley Road, Melbourne, VIC 3084, Australia.ORCID 0000-0003-4007-7849
Claudio RoncoInternational Renal Research Institute of Vicenza, 36100 Vicenza, Italy.
Silvia De RosaInternational Renal Research Institute of Vicenza, 36100 Vicenza, Italy.ORCID 0000-0001-8987-4596
International Renal Research Institute of Vicenza · ITOspedale San Bortolo · ITUniversity of Padua · ITHumanitas University · ITThe University of Melbourne · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Acute kidney injury (AKI) is a common cause of organ failure in trauma patients who survive their initial injuries. It is independently associated with increased morbidity and mortality and prolongs the length of hospital stays. The objectives of this study were to describe the incidence of early AKI and influence of risk factors in polytrauma patients and evaluate the predictive potential of TIMP2 × IGFBP7 biomarkers in this patient cohort. Methods: We conducted a retrospective cohort study of severely injured adult patients who were consecutively admitted to a multidisciplinary ICU from May 2017 to May 2019. Detailed patient data was retrieved from ICU medical records. Fluid balance, urinary output, and sCr values up to 72 h were collected. Urine samples for measuring TIMP2 × IGFBP7 concentrations were obtained and analyzed from ICU admission to 72 h. Results: Among the 153 patients eligible for analysis, 45 were included in the AKI, and 108 in the no AKI cohorts. The incidence of AKI within 72 h, based on KDIGO criteria, was 28.8%. There were no differences in ISS, type and mechanism of injury, heart rate, and systolic BP at admission between groups. Patients with early AKI were older (68 vs. 49 years, p < 0.001), obese (BMI 26.2 vs. 24.7, p < 0.048), and more likely to have previous cardiac disease (27% vs. 5.6%, p < 0.001). TIMP2 × IGFBP7 values on ICU admission were associated with subsequent AKI in patients without evidence of AKI at the time of ICU admission. They were also higher in the AKI cohort and significantly correlated with renal replacement therapy (RRT) and episodes of hypotension. Multivariable analysis confirmed age, previous cardiac disease, and NephroCheck as the variables mostly associated with AKI, with AUC 0.792. Conclusions: TIMP2 × IGFBP7 may help identify trauma patients with tubular damage that may evolve into a clinically manifested syndrome. Prospective studies of TIMP2 × IGFBP7, as a trigger for early AKI bundle care, are warranted.

Indexed as

acute kidney injuryIGFBP7intensive care unitoutcomesTIMP2trauma

Identifiers

PMID36292170
PMCPMC9601128
OpenAlexW4306149656

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.